Abstract
Pregnancy loss (PL) is one of the common complications that women can experience during pregnancy, with an occurrence rate of 1 to 5%. The potential causes of pregnancy loss are unclear, with no effective treatment modalities being available. It has been previously reported that the level of miR-125b was significantly increased in placentas of PL patients. However, the role of miR-125b in the development of PL still remains unknown. In the current study, an miR-125b placenta-specific over-expression model was constructed by lentiviral transfecting zona-free mouse embryos followed by embryo transfer. On gestation day 15, it was observed that the placenta was significantly smaller in the miR-125b placenta-specific overexpression group than the control group. Additionally, the abortion rate of the miR-125b placenta-specific overexpression group was markedly higher than in the control group. The blood vessel diameter was larger in the miR-125b-overexpressing specific placenta. In addition, miR-125b-overexpressing HTR8 and JEG3 cell lines were also generated to analyze the migration and invasion ability of trophoblasts. The results showed that miR-125b overexpression significantly suppressed the migration and invasion ability of HTR8 and JEG3 cells. Overall, our results demonstrated that miR-125b can affect embryo implantation through modulating placenta angiogenesis and trophoblast cell invasion capacity that can lead to PL.
Original language | English |
---|---|
Article number | 943 |
Journal | International Journal of Molecular Sciences |
Volume | 23 |
Issue number | 2 |
DOIs | |
Publication status | Published - 1 Jan 2022 |
Externally published | Yes |
Bibliographical note
Funding Information:Funding: This work was supported by the Natural Sciences Foundation of China (81771617, 32072815), technology innovation leading program of Shaanxi province(2020QFY10), the general project of the key R & D plan of Shaanxi province (2019NY-091), program of Shaanxi province science and technology innovation team (2019TD-036) and the fundamental research funds for the central universities (2452020157).
Publisher Copyright:
© 2022 by the authors. Licensee MDPI, Basel, Switzerland.